Fausto Petrelli

14.7k total citations · 4 hit papers
280 papers, 9.1k citations indexed

About

Fausto Petrelli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Fausto Petrelli has authored 280 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Oncology, 122 papers in Pulmonary and Respiratory Medicine and 70 papers in Surgery. Recurrent topics in Fausto Petrelli's work include Colorectal Cancer Treatments and Studies (57 papers), Cancer Treatment and Pharmacology (39 papers) and Gastric Cancer Management and Outcomes (38 papers). Fausto Petrelli is often cited by papers focused on Colorectal Cancer Treatments and Studies (57 papers), Cancer Treatment and Pharmacology (39 papers) and Gastric Cancer Management and Outcomes (38 papers). Fausto Petrelli collaborates with scholars based in Italy, United Kingdom and United States. Fausto Petrelli's co-authors include Sandro Barni, Mary Cabiddu, Karen Borgonovo, Mara Ghilardi, Michele Ghidini, Gianluca Tomasello, Andrea Coinu, Antonio Ghidini, Veronica Lonati and Giovanni Sgroi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgery.

In The Last Decade

Fausto Petrelli

273 papers receiving 9.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer

2016 511 citations Fausto Petrelli, Gianluca Tomasello et al. profile →
Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: A meta-analysis

2015 350 citations Filippo Pietrantonio, Fausto Petrelli et al. European Journal of Cancer profile →
Association of Obesity With Survival Outcomes in Patients With Cancer

2021 302 citations Fausto Petrelli, Alice Indini et al. profile →
Total Neoadjuvant Therapy in Rectal Cancer

2019 239 citations Fausto Petrelli, Francesca Trevisan et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Fausto Petrelli	5.9k	3.2k	2.3k	1.7k	1.3k	280	9.1k
Tim Maughan	5.0k 0.8×	2.5k 0.8×	2.4k 1.0×	1.1k 0.7×	1.1k 0.8×	243	7.7k
Jee Hyun Kim	5.2k 0.9×	2.9k 0.9×	1.8k 0.8×	1.4k 0.8×	1.5k 1.1×	320	8.1k
Bruno Vincenzi	6.2k 1.0×	3.2k 1.0×	1.6k 0.7×	2.0k 1.2×	2.6k 1.9×	428	11.0k
Giuseppe Aprile	5.6k 0.9×	5.0k 1.6×	2.5k 1.1×	1.3k 0.8×	2.0k 1.5×	232	9.8k
Alberto Zaniboni	6.3k 1.1×	2.5k 0.8×	1.5k 0.6×	1.5k 0.9×	1.1k 0.8×	301	8.1k
David Khayat	5.3k 0.9×	2.6k 0.8×	1.1k 0.5×	1.4k 0.9×	2.4k 1.8×	108	8.4k
H. Cortés-Funes	6.4k 1.1×	2.6k 0.8×	2.1k 0.9×	1.3k 0.8×	1.8k 1.3×	192	9.6k
Jean‐Luc Van Laethem	7.9k 1.3×	3.2k 1.0×	3.4k 1.5×	2.2k 1.3×	1.4k 1.0×	275	10.4k
Donna Hollis	5.9k 1.0×	4.6k 1.4×	3.0k 1.3×	1.5k 0.9×	1.3k 0.9×	154	11.4k
Ashley E. Winkler	3.9k 0.7×	2.5k 0.8×	1.4k 0.6×	848 0.5×	1.1k 0.9×	12	7.3k

Countries citing papers authored by Fausto Petrelli

Since Specialization

Citations

This map shows the geographic impact of Fausto Petrelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fausto Petrelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fausto Petrelli more than expected).

Fields of papers citing papers by Fausto Petrelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fausto Petrelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fausto Petrelli. The network helps show where Fausto Petrelli may publish in the future.

Co-authorship network of co-authors of Fausto Petrelli

This figure shows the co-authorship network connecting the top 25 collaborators of Fausto Petrelli. A scholar is included among the top collaborators of Fausto Petrelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fausto Petrelli. Fausto Petrelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Petrelli, Fausto, Lorenza Bruschieri, Antonella Villa, et al.. (2025). First-line treatment of locally advanced cervical carcinoma: An updated systematic review and Bayesian network meta-analysis. Cancer Treatment Reviews. 135. 102921–102921.

2.

Petrelli, Fausto, Luigi Lorini, Alberto Paderno, et al.. (2025). Treatment of primary tumor in metastatic head and neck Carcinoma: A systematic review and Meta-Analysis. Oral Oncology. 163. 107248–107248. 1 indexed citations

3.

Petrelli, Fausto, Francesca Trevisan, Massimiliano Nardone, et al.. (2025). Non-cisplatin concurrent agents plus definitive radiotherapy for locally advanced head and neck cancer: A network meta-analysis of randomized studies. Radiotherapy and Oncology. 210. 111033–111033.

4.

Petrelli, Fausto, et al.. (2024). Localized prostate cancer in older patients: Radical prostatectomy or radiotherapy versus observation. Journal of Geriatric Oncology. 15(6). 101792–101792. 3 indexed citations

5.

Paderno, Alberto, Fausto Petrelli, Luigi Lorini, et al.. (2024). The predictive role of PD-L1 in head and neck cancer: A systematic review and meta-analysis. Oral Oncology. 153. 106799–106799. 10 indexed citations

6.

Petrelli, Fausto, Maria Antista, Fulvia Milena Cribiù, et al.. (2024). Adjuvant and neoadjuvant chemotherapy for MSI early gastric cancer: a systematic review and meta-analysis. Therapeutic Advances in Medical Oncology. 16. 12675995–12675995. 5 indexed citations

7.

Pivot, Xavier, Alexey Manikhas, Hwoei Fen Soo Hoo, et al.. (2023). Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant setting. BMC Cancer. 23(1). 112–112. 2 indexed citations

8.

Petrelli, Fausto, Lorenzo Dottorini, Giandomenico Di Menna, et al.. (2023). The role of CDK4/6 inhibitors in older and younger patients with breast cancer: A systematic review and meta-analysis. The Breast. 71. 138–142. 9 indexed citations

9.

Tomasello, Giovanni, Donatella Gambini, Fausto Petrelli, et al.. (2022). Characterization of the HER2 status in BRCA-mutated breast cancer: a single institutional series and systematic review with pooled analysis. ESMO Open. 7(4). 100531–100531. 12 indexed citations

10.

Petrelli, Fausto, Antonio Ghidini, Michele Ghidini, et al.. (2021). Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies. F1000Research. 10. 423–423.

11.

Tomasello, Gianluca, Michele Ghidini, Antonio Ghidini, et al.. (2021). Total neoadjuvant therapy for initially inoperable pancreatic cancer: A systematic review of phase 2–3 studies. Radiotherapy and Oncology. 164. 13–19. 8 indexed citations

12.

Petrelli, Fausto, Antonio Ghidini, Michele Ghidini, et al.. (2021). Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies. F1000Research. 10. 423–423. 4 indexed citations

13.

Petrelli, Fausto, Antonio Ghidini, Michele Ghidini, et al.. (2021). Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies. F1000Research. 10. 423–423. 8 indexed citations

14.

Bersanelli, Melissa, Fausto Petrelli, Sebastiano Buti, & Ignazio Stanganelli. (2021). Immune checkpoint inhibitors in adjuvant setting after radical resection of melanoma: a meta-analysis of the pivotal trials. Human Vaccines & Immunotherapeutics. 18(3). 1902723–1902723. 2 indexed citations

15.

Petrelli, Fausto, Alessandro Iaculli, Diego Signorelli, et al.. (2020). Survival of Patients Treated with Antibiotics and Immunotherapy for Cancer: A Systematic Review and Meta-Analysis. Preprints.org. 11 indexed citations

16.

Indini, Alice, Fausto Petrelli, Gianluca Tomasello, et al.. (2020). Impact of Use of Gastric-Acid Suppressants and Oral Anticancer Agents on Survival Outcomes: A Systematic Review and Meta-Analysis. Preprints.org. 4 indexed citations

17.

Consoli, Francesca, Melissa Bersanelli, Gianluca Perego, et al.. (2019). Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanoma. Clinical & Translational Oncology. 22(6). 900–907. 8 indexed citations

18.

Petrelli, Fausto, Michele Ghidini, Veronica Lonati, et al.. (2017). The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: A systematic review and pooled analysis. European Journal of Cancer. 84. 141–148. 89 indexed citations

19.

Petrelli, Fausto, Gianluca Tomasello, Sandro Barni, et al.. (2017). Clinical and pathological characterization of HER2 mutations in human breast cancer: a systematic review of the literature. Breast Cancer Research and Treatment. 166(2). 339–349. 62 indexed citations

20.

Petrelli, Fausto, Serena Di Cosimo, Veronica Lonati, & Sandro Barni. (2016). Vinorelbine With Capecitabine, an Evergreen Doublet for Advanced Breast Cancer: A Systematic Literature Review and Pooled-Analysis of Phase II-III Studies. Clinical Breast Cancer. 16(5). 327–334. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact